Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Pilot Study

NCT04047602 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.

NCT NCT04047602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04047602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Pilot Study
Lead sponsor
Indiana University
Phase
Not applicable
Overall status
Terminated
Start date
December 12, 2019
Completion date
February 20, 2024
Enrollment
18 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

brain cancer, brain metastases, brain tumor